Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in HFPEF with Pulmonary Hypertension (BADDHY)
NCT00820352Phase 3Completed
- Sponsor
- University Teaching Hospital Hall in Tirol
- Start
- Jan 2009
- Primary completion
- Jun 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bosentan in heart failure with preserved ejection fraction (HFpEF), pulmonary hypertension (PH), sponsored by University Teaching Hospital Hall in Tirol. Started Jan 2009; status: completed.
02
Drugs
bosentan
03
Conditions
heart failure with preserved ejection fraction (HFpEF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00820352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820352.